A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies
Autor: | Gordon, Max J. 1, ∗, Dubois, Sigrid 1, Miljkovic, Milos D. 1, 2, Ng, Samuel 1, Bryant, Bonita 1, Lakhotia, Rahul 1, Melani, Christopher 1, Pittaluga, Stefania 3, Conlon, Kevin 1, Waldmann, Thomas 1, Staudt, Louis M. 1, Wilson, Wyndham H. 1, Roschewski, Mark 1 |
---|---|
Zdroj: | In Blood Neoplasia February 2025 2(1) |
Databáze: | ScienceDirect |
Externí odkaz: |